What's new

Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 11, Status: Authorised

May 13, 2025 - 15:54
 0
Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

EMEA-002876-PIP02-23

Next Article

Human medicines European public assessment report (EPAR): Tobi Podhaler, tobramy...

Related Posts

PSUSA/00010239/202408

PSUSA/00010239/202408

May 7, 2025  0

Human medicines European public assessment report (EPAR): Posaconazole Accord, posaconazole, Date of authorisation: 25/07/2019, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

May 6, 2025  0

New product information wording: extracts from PRAC rec...

May 5, 2025  0